Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
hepatocellular-carcinoma
advanced hepatocellular carcinoma, adebrelimab, camrelizumab, apatinib, hepatocellular carcinoma, first-line therapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 888340
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.